These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses. Jiang WM, Wang SC, Liu HL, Yu JM, Du X, Hou GY, Li JP, Liu S, Wang KC, Zhuang QY, Liu XM, Chen JM. Vaccine; 2014 Nov 12; 32(48):6433-9. PubMed ID: 25285880 [Abstract] [Full Text] [Related]
24. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ, Gabbard JD, Li Z, Dlugolenski DA, Johnson SK, Tripp RA, He B, Tompkins SM. J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931689 [Abstract] [Full Text] [Related]
25. Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans. Overton ET, Goepfert PA, Cunningham P, Carter WA, Horvath J, Young D, Strayer DR. Vaccine; 2014 Sep 22; 32(42):5490-5. PubMed ID: 25128802 [Abstract] [Full Text] [Related]
27. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1). Matassov D, Cupo A, Galarza JM. Viral Immunol; 2007 Sep 22; 20(3):441-52. PubMed ID: 17931114 [Abstract] [Full Text] [Related]
29. Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice. Wang Y, Zhang Y, Wu J, Lin Y, Wu Z, Wei Y, Wei X, Qin J, Xue C, Liu GD, Cao Y. Virus Res; 2017 Oct 15; 242():16-23. PubMed ID: 28912070 [Abstract] [Full Text] [Related]
31. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice. Tian X, Landreth S, Lu Y, Pandey K, Zhou Y. J Virol; 2021 Jan 13; 95(3):. PubMed ID: 33177192 [Abstract] [Full Text] [Related]
32. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant. Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J. J Virol; 2015 Oct 13; 89(20):10612-24. PubMed ID: 26269188 [Abstract] [Full Text] [Related]
39. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice. Harada Y, Ninomiya-Mori A, Takahashi Y, Shirakura M, Kishida N, Kageyama T, Tada Y, Tashiro M, Odagiri T. Vaccine; 2011 Oct 26; 29(46):8330-7. PubMed ID: 21911027 [Abstract] [Full Text] [Related]